Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery - Wikidata - wikimedia - TriplyDB

Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery

Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery

http://www.wikidata.org/entity/Q33853399

about

Ectopic expression of KCNE3 accelerates cardiac repolarization and abbreviates the QT interval Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction Beta-Adrenergic gene therapy for cardiovascular disease Gene therapy targets in heart failure: the path to translation Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo β2-adrenoceptor transfection enhances contractile reserve of isolated rat ventricular myocytes exposed to chronic isoprenaline stimulation by improving β1-adrenoceptor responsiveness Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications.Cardioprotection specific for the G protein Gi2 in chronic adrenergic signaling through beta 2-adrenoceptors.Cardiac gene therapy: optimization of gene delivery techniques in vivo.Cardiac gene therapy Genetic manipulation of beta-adrenergic signalling in heart failure.Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?Rescuing the failing heart by targeted gene transfer Targeting calcium cycling proteins in heart failure through gene transfer.Emerging therapeutic targets in chronic heart failure: part II.Targeting signaling pathways in heart failure by gene transfer.Gene therapy for heart failure.The evolution of heart gene delivery vectors Targeted high-efficiency, homogeneous myocardial gene transfer.Thr164Ile polymorphism of beta2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy.Myocardial β(2) -adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure.Potential of gene therapy as a treatment for heart failure Ventricular-assist devices for the treatment of chronic heart failure.Current strategies for myocardial gene delivery.Gene therapy in heart failure.Designing heart performance by gene transfer.Gene therapy to treat cardiovascular disease.Cardiac gene therapy with SERCA2a: from bench to bedside Cardiac gene therapy: from concept to reality.Lentiviral vectors and cardiovascular diseases: a genetic tool for manipulating cardiomyocyte differentiation and function.Gene therapy for heart failure: where do we stand?Percutaneous approaches for efficient cardiac gene delivery.Therapeutic potential of genes in cardiac repair.Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium.Cardiac gene therapy: are we there yet?Emerging therapies for heart failure.Left ventricular targeting of reporter gene expression in vivo by human BNP promoter in an adenoviral vector.Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model.Overexpression of beta 1 and beta 2 adrenergic receptors in rat atrial myocytes. Differential coupling to G protein-gated inward rectifier K(+) channels via G(s) and G(i)/o.In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo.

P2860

Q24551736-18591CD9-A9B4-4D20-BDD9-8D3E83D05539 Q24656335-C330E7C6-62DE-4EEA-B591-6C682C7BFE8A Q24792845-B251BA6E-5D91-40B7-A516-1B7110F77E57 Q27022444-39483EAA-20B8-4313-BBDD-13DBEB3D5612 Q28360110-17B6BE45-F309-417B-9F05-EF6EE832CB88 Q28573247-16E61FEB-DE01-4E3A-8758-2ED89AFB8A8D Q30427066-C5CE2A2E-8ADE-48BB-9F36-FDE4C82FB097 Q33717958-AF3577D5-7C3F-4732-B2D3-398859AC9A8F Q33832137-2646913C-B5B6-4896-A405-281F973EF33F Q34409721-8ACCCEFE-4910-472F-A9D2-3B88A4F6EEE5 Q34419016-2953D0C9-CDFB-4C91-8978-F2007DF0FB9F Q34482530-472773C1-C2A6-454A-B44E-6A6EF40E7B55 Q34757960-4CF00676-C4A1-4B5D-A926-0766EDBBF94C Q35037546-37688B1C-A3DF-476C-AC5B-90DF32C1DE54 Q35056026-1DA714EB-C709-4F8A-85B8-D1D2C6E36FE8 Q35095401-FCF7A3CF-C7D0-4ACB-9704-89B920E7B313 Q35791499-684C91F4-FAF9-43F9-90EB-153B5670CB37 Q35799722-E19A44CF-018C-4292-A78A-6CFBEF9E6BAE Q35990749-5678724D-99C5-415F-B96E-8F2C64C56657 Q36014089-145ABD35-7A9E-4AEE-85A6-AFF391F8D8A2 Q36252791-9D49FC63-0578-4CA1-BE18-21A54C894D29 Q36497159-E953718C-23E2-4249-877F-9518DEB523B6 Q36815993-BC4C647B-7BA4-445E-8C69-93223F50BF12 Q36931967-EE49E7ED-1DE3-44B4-B0AA-482AF5D71FB9 Q36944623-9B20BB12-616C-43D7-96B4-7598E4F5658E Q37299072-229694AA-E2F5-4A25-872D-3598388A0D5C Q37310450-37200F97-0699-431E-953E-0020B0085650 Q37811189-E36FB23F-4E1A-41E7-8C2F-B33D1964FEDA Q37965045-FE93CC2F-CE45-4403-8587-65EE4E7512A0 Q37989402-F9BB545A-5285-42F6-9D64-FCC666592208 Q38073152-60D1F6A1-FFBB-4FAF-9163-42B6E6FF094A Q38113171-7F5CF370-13FB-4B7F-BE15-EC658800EFCE Q38128924-7032476D-08B6-49A7-8078-26F279BDA830 Q38132253-320F2195-07B2-4A3F-B178-180E1DAB8F0F Q38820937-EC73DE46-F920-4B14-8022-DC74D54FA238 Q40409363-D2814828-0871-437F-A253-C2EB2A0FC99F Q40703867-22369285-1DA0-4A85-9259-FB02103CAB89 Q41890749-B160AE33-5C5F-4E81-A84F-BCCD60BC4F33 Q43701650-DF7E1086-1069-46B9-8ED5-94205BB99875 Q43856052-ACD0415C-FA75-41FC-A5DD-818A2922715A

P2860

Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery

http://www.wikidata.org/entity/Q33853399

description

1999 nî lūn-bûn

@nan

1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Enhancement of cardiac functio ...... energic receptor gene delivery

@ast

Enhancement of cardiac functio ...... energic receptor gene delivery

@en

type

label

Enhancement of cardiac functio ...... energic receptor gene delivery

@ast

Enhancement of cardiac functio ...... energic receptor gene delivery

@en

prefLabel

Enhancement of cardiac functio ...... energic receptor gene delivery

@ast

Enhancement of cardiac functio ...... energic receptor gene delivery

@en

P1433

Q33853399-FFC5505C-08FB-4A72-8399-92BBAFB9823F

P1476

Q33853399-57610B32-3072-4E41-8501-2C68336FA15C

P2093

Q33853399-047DD7F9-22B1-4322-AAD4-61A74A1F5326

Q33853399-2CB28916-6E45-4247-A547-9002130EF86A

Q33853399-479B9FCB-C6D5-4506-934C-62EB8AEE59A4

Q33853399-6FFEFC83-8F7F-4661-84E3-57BFC4A300EC

Q33853399-71A7FED1-08DC-4E7D-BB86-FE3A606ED1F4

Q33853399-A518872D-44AD-446E-8525-3B02C9C701DA

Q33853399-BB0AB4E6-1CFB-43E7-B0FA-87BA85EA1763

Q33853399-CBAB17E3-001C-45F3-BC3C-E4E4658D4A3A

Q33853399-D0F401AC-CAB9-4098-9229-F91C6DB91980

Q33853399-DA154FBF-E5A3-4EAE-8F29-185D1A51AF6C

P2860

Q33853399-2B21F698-CC1E-4E13-84F2-3156C8FE3407

Q33853399-5A79AF47-8908-40B8-8BA7-8398C84BFBE3

Q33853399-5DBA7115-164B-4293-A974-A60FBB86621A

Q33853399-61E69D36-03F5-4C1B-AD3B-A5BD67F69C8C

Q33853399-65018DDE-A7A0-4289-9BC8-B03BD95D66DE

Q33853399-66BCDCAE-AA4B-44AA-B435-F68C5C241569

Q33853399-78B69235-860B-4FA2-B302-7489BB2EB535

Q33853399-7E8A5A99-6A8D-4B42-A21B-EB05AD8398D5

Q33853399-8BFDE9D2-88BB-4BCE-880E-18B91C9032D2

Q33853399-968E73B1-FF43-43C8-BBAD-4385B04BC1DA

P304

Q33853399-354AC29D-CBC4-42CB-90DB-57B7B4F2573B

P31

Q33853399-16A23FD2-75B1-491C-9B34-450C5F826E69

P356

Q33853399-202E0DCE-8659-4F58-A4F3-56B477DD7047

P407

Q33853399-BF4E9B60-F70B-4958-841C-CB9B6552C61F

P433

Q33853399-E2120F5D-116F-43F4-8F32-968A12A371A8

P478

Q33853399-ACF8C9DF-B455-49E8-8095-D4853610C332

P577

Q33853399-E2251735-393D-4D0B-8FB8-19C2DB74015F

P698

Q33853399-5ECF3939-9ECA-4655-AAB7-C36015D9CD8E

P921

Q33853399-C7CBBD4C-77AF-4A6A-A3A9-5CCCD4959F6C

P932

Q33853399-D7B2710E-D862-4588-91E0-7F3A633FDB32

P356

P1433

Journal of Clinical Investigation

P1476

Enhancement of cardiac functio ...... energic receptor gene delivery

@en

P2093

A S Shah

http://www.w3.org/2001/XMLSchema#string

D C White

http://www.w3.org/2001/XMLSchema#string

D D Glower

http://www.w3.org/2001/XMLSchema#string

J A Hata

http://www.w3.org/2001/XMLSchema#string

J P Maurice

http://www.w3.org/2001/XMLSchema#string

K H Wilson

http://www.w3.org/2001/XMLSchema#string

P C Dolber

http://www.w3.org/2001/XMLSchema#string

P H McDonald

http://www.w3.org/2001/XMLSchema#string

R J Lefkowitz

http://www.w3.org/2001/XMLSchema#string

W J Koch

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor

Reduced beta 1 receptor messenger RNA abundance in the failing human heart.

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver

Modulation of ventricular function through gene transfer in vivo.

Ultrarapid, highly efficient viral gene transfer to the heart

Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer

Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo.

Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice.

Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice.

Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes

P304

21-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI6026

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

1999-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10393695

http://www.w3.org/2001/XMLSchema#string

P921

P932

408402

http://www.w3.org/2001/XMLSchema#string